"No warning can save people determined to grow suddently rich" - Lord Overstone

  • 41 mins 5 Big Drivers of Higher Inflation Rates Ahead
  • 2 hours U.S. And China To Face Off Over Aramco IPO
  • 5 hours Gold Bulls, Brace Yourselves – Fed Hikes Are Coming!
  • 8 hours Stocks Fail to Hold Gains, But Still No Correction
  • 10 hours Cryptojacking: A New Threat Vector To Critical Infrastructure
  • 1 day Why The Next Oil Boom Will Be Fueled By Blockchain
  • 1 day 5 Things Investors Should Know About China this New Year
  • 1 day Is The South Korean Crypto-Drama Finally Over?
  • 1 day Miners’ Rally? What Rally? Watch Out for More Fake Moves!
  • 1 day Four Percent 10-year Note Yield Will Be a Floor Not a Ceiling
  • 1 day The End Is Near
  • 2 days 5 Record Breaking Gemstones Even Billionaires Can’t Buy
  • 2 days Irredeemable Currency De-tooths Savers
  • 2 days CFTC Offers Bounty For Crypto Pump And Dump Whistleblowers
  • 2 days Have You Been Getting Run Over By This Stock Market Action?
  • 2 days Decision Time
  • 2 days 1 Week Later, Risk Remains ‘On’ as 2 of 3 Amigos Ride On
  • 3 days The Most Polarized Commodity Ever
  • 3 days Commodity Coins and Us: What To Expect From The "Tokenization of Everything"
  • 3 days U.S. Dollar Bull and Bear Markets
U.S. Dollar Bull and Bear Markets

U.S. Dollar Bull and Bear Markets

The idea of endlessly repeated…

Mark Valek

Mark Valek

Mark is founding partner and investment manager of Incrementum AG. Together with Ronald Stoeferle he manages a global macro fund, which is based on the…

More Info

Ronald-Peter Stoferle

Ronald-Peter Stoferle

Ronald, born 1980 in Vienna, Austria, is a Chartered Market Technician (CMT) and a Certified Financial Technician (CFTe). During his studies in business administration and…

More Info

In Gold We Trust 2016 - Compact Version

Gold is back! With the strongest quarterly performance in 30 years, the precious metal in Q1 2016 emerged from the bear market that had been in force since 2013. A decisive factor in this comeback is growing uncertainty over the recovery of the post-Lehman economy. After years of administering high doses of monetary painkillers, will the Fed succeed in discontinuing the practice? Or is the entire therapy about to be fundamentally questioned?

In Gold We Trust 2016 - Compact Version

The extended version is available at http://www.incrementum.li/en/research-analysis/in-gold-we-trust-2016/

 

Read the Report

Back to homepage

Leave a comment

Leave a comment




Don't Miss A Single Story